CNST Gross Margin

The Gross Margin of Constellation Pharmaceuticals Inc (CNST) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CNST Gross Margin - Peers Comparison

Ticker	Name	Value
GTHR	GeneThera Inc	100.00%
REGN	Regeneron Pharmaceuticals Inc	87.01%
950160.KQ	Kolon TissueGene Inc	11.72%
AMGN	Amgen Inc	68.71%
EPRSQ	EPIRUS Biopharmaceuticals Inc	82.17%
FWP	Forward Pharma A/S	98.00%
LBL.V	Lattice Biologics Ltd	41.41%
PLX	Protalix Biotherapeutics Inc	54.46%
VBIX	Viewbix Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
ABBV	Abbvie Inc	69.99%
AVXT	AVAX Technologies Inc	51.07%
GILD	Gilead Sciences Inc	78.26%
RASP	Rasna Therapeutics Inc	7775.20%
SGBI	Sangui Biotech International Inc	100.00%
BSYI	Biosyntech Inc	60.98%
IMNPQ	Immune Pharmaceuticals Inc	26.60%
IMUN	Immune Therapeutics Inc	58.00%
VRTX	Vertex Pharmaceuticals Inc	86.11%
BSTG	Biostage Inc	-41.46%
MRNA	Moderna Inc	70.06%
950200.KQ	Psomagen Inc	23.13%
CLCS	Cell Source Inc	7775.20%
CYTH	Cyclo Therapeutics Inc	90.85%
GBIM	Globeimmune Inc	95.54%
ATRX	Adhera Therapeutics Inc	-62.30%
CRXM	Gene Biotherapeutics Inc	36.67%
PZRXQ	PZ Wind Down Inc	7775.20%
RGBOQ	Regen Biologics Inc	49.56%
ALSE	Alseres Pharmaceuticals Inc	7775.20%
CGNH	CardioGenics Holdings Inc	-600.00%
HCYT	H-Cyte Inc	74.07%
MCET	Multicell Technologies Inc	7775.20%
MYMX	Mymetics Corp	-40.19%
PHIO	Phio Pharmaceuticals Corp	7775.20%
PKPH	Peak Pharmaceuticals Inc	7775.20%